<DOC>
	<DOCNO>NCT02855073</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness ReJoinTM Knee Osteoarthritis patient Cartilage Defects compare Sodium Hyaluronate Injection .</brief_summary>
	<brief_title>Clinical Trial Compare ReJoinTM Sodium Hyaluronate Injection Knee Osteoarthritis Cartilage Defects</brief_title>
	<detailed_description>This randomize , single-blind , parallel group , phase II clinical trial . 28 subject clinical diagnosis knee osteoarthritis cartilage defect randomly distribute 2:1 treatment group control group sign ICF screen tests.The treatment accept ReJoinTM first fourth week , Sodium Hyaluronate Injection second third week.The control group accept Sodium Hyaluronate Injection weekly , four injection total.The duration therapy 48 week .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Cartilage Diseases</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1870 year old , KOA couse ≤ 10 year KellgrenLawrence ⅠⅢ VAS core ＞6， 4 month Signed informed consent subject cartilage defect 26cm2 Pregnancy test positive . Subject infected hepatitis C , HIV syphilis . Subject enrol cell therapy study within past 30 day . Subject deem suitable study investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adipose-derived mesenchymal progenitor cell</keyword>
	<keyword>Artz</keyword>
</DOC>